Diabetes drug combo shows promise in blood sugar control
NCT ID NCT02220920
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tested whether adding canagliflozin to insulin helps people with type 2 diabetes control their blood sugar better. 146 adults on stable insulin therapy took either the drug or a placebo for 16 weeks. Researchers measured changes in blood sugar, weight, and blood pressure, and monitored side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Chugoku, Japan
-
Reserch site
Chūbu, Japan
-
Reserch site
Hokkaido, Japan
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Kyushu, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.